ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Synthetic Biology

Culture Biosciences raises $15 million for bioreactor service

by Melody M. Bomgardner
March 15, 2020 | APPEARED IN VOLUME 98, ISSUE 10

 

09810-buscon13-culture.jpg
Credit: Culture Biosciences
Culture Biosciences has bioreactors that clients can access via the cloud.

Culture Biosciences has raised $15 million in a first round of funding led by Cultivian Sandbox Ventures. San Francisco–based Culture serves companies working to scale up synthetic biology discoveries by renting bioreactors that connect to the cloud. Many companies have a backlog of potential products such as alternative proteins, biobased chemicals, and pharmaceuticals to try out at scale but lack facilities to move them forward, Culture says. Its clients include Zymergen, Clara Foods, Nektar Therapeutics, C16 Biosciences, and Boost Biomes.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment